elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38750614-BF072ACD-AA42-4652-9D74-796232F6699E
Q38750614-BF072ACD-AA42-4652-9D74-796232F6699E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38750614-BF072ACD-AA42-4652-9D74-796232F6699E
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes.
P304
Q38750614-BF072ACD-AA42-4652-9D74-796232F6699E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38750614-BF072ACD-AA42-4652-9D74-796232F6699E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8843dc825e34a07004fe43fd1997727e6b63846d
P304
1403-1416
http://www.w3.org/2001/XMLSchema#string